Publications by authors named "Lori Beck"
Reproductive and sexual health (RSH) is an important component of wellness and recovery for people with substance use disorder (SUD). Evidence to guide better integration of RSH services into SUD treatment is limited. Our objectives were to compare 1) unmet RSH needs; and 2) barriers to RSH service utilization between care settings providing treatment for SUD or other chronic medical conditions.
View Article and Find Full Text PDFArticle Synopsis
- Chronic pain, specifically Chronic Pelvic Pain (CPP), significantly complicates opioid use disorder (OUD), with overlapping psychosocial and neurobiological risks.
- The study aimed to compare the prevalence of CPP and sexual dysfunction between individuals on buprenorphine for OUD and those receiving treatment for other chronic medical conditions, using various assessment tools.
- Findings indicated high levels of CPP and sexual dysfunction in both groups, highlighting the need for integrated, gender-sensitive approaches in OUD treatment to improve recovery outcomes.
Article Synopsis
- * A study showed that over a third of OUD participants reported experiencing recent IPT, with women more frequently affected by sexual violence than men.
- * The findings suggest that public health strategies addressing the opioid crisis should specifically consider the impacts of IPT, focusing on tailored approaches for different genders.
Objectives: Disparities in substance use disorder (SUD) treatment use persist across groups, including gender. Using a gender-informed approach to expand treatment capacity and reduce barriers to treatment engagement is vital. We examined SUD treatment need and receipt among people with SUD in the United States, by gender, and assessed gender-specific sociodemographic factors associated with unmet need for SUD treatment and reported treatment barriers.
View Article and Find Full Text PDFBackground: People with opioid use disorder (OUD) are disproportionately burdened by HIV. The United States' Centers for Disease Control and Prevention (CDC) has issued guidelines for pre-exposure prophylaxis (PrEP) indication. We know little about PrEP for people receiving medication for OUD.
View Article and Find Full Text PDF